CHS INC - CHSINC 8 PERP (CHSCP) Fundamental Analysis & Valuation
NASDAQ:CHSCP • US12542R2094
Current stock price
27.56 USD
-0.1 (-0.36%)
Last:
This CHSCP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHSCP Profitability Analysis
1.1 Basic Checks
- In the past year CHSCP had a positive cash flow from operations.
- Each year in the past 5 years CHSCP has been profitable.
- In the past 5 years CHSCP always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.96%, CHSCP is in line with its industry, outperforming 56.32% of the companies in the same industry.
- CHSCP has a Return On Equity of 5.48%. This is comparable to the rest of the industry: CHSCP outperforms 56.32% of its industry peers.
- The Return On Invested Capital of CHSCP (0.37%) is comparable to the rest of the industry.
- The Average Return On Invested Capital over the past 3 years for CHSCP is below the industry average of 6.78%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROIC | 0.37% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
- CHSCP has a Profit Margin (1.75%) which is in line with its industry peers.
- In the last couple of years the Profit Margin of CHSCP has grown nicely.
- CHSCP has a worse Operating Margin (0.21%) than 62.07% of its industry peers.
- CHSCP's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 3.21%, CHSCP is doing worse than 83.91% of the companies in the same industry.
- In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. CHSCP Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
- Compared to 1 year ago, CHSCP has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.11 indicates that CHSCP is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of CHSCP (2.11) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.32 indicates that CHSCP is not too dependend on debt financing.
- CHSCP has a Debt to Equity ratio of 0.32. This is in the better half of the industry: CHSCP outperforms 60.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.11 |
ROIC/WACC0.07
WACC5.55%
2.3 Liquidity
- A Current Ratio of 1.42 indicates that CHSCP should not have too much problems paying its short term obligations.
- CHSCP's Current ratio of 1.42 is in line compared to the rest of the industry. CHSCP outperforms 43.68% of its industry peers.
- A Quick Ratio of 0.80 indicates that CHSCP may have some problems paying its short term obligations.
- CHSCP has a Quick ratio of 0.80. This is comparable to the rest of the industry: CHSCP outperforms 44.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 |
3. CHSCP Growth Analysis
3.1 Past
- CHSCP shows a decrease in Revenue. In the last year, the revenue decreased by -5.74%.
- The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CHSCP Valuation Analysis
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCP indicates a rather cheap valuation: CHSCP is cheaper than 93.10% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.4 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CHSCP Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 7.23%, CHSCP is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 2.22, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 94.25% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, CHSCP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.23% |
5.2 History
- CHSCP has paid a dividend for at least 10 years, which is a reliable track record.
- CHSCP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years22
5.3 Sustainability
- CHSCP pays out 27.52% of its income as dividend. This is a sustainable payout ratio.
DP27.52%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCP Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CHSCP (4/21/2026, 4:30:00 PM)
27.56
-0.1 (-0.36%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-15 2026-04-15
Earnings (Next)07-07 2026-07-07
Inst Owners11.07%
Inst Owner Change-0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap338.16M
Revenue(TTM)35.03B
Net Income(TTM)613.61M
Analysts0
Price TargetN/A
Short Float %0.21%
Short Ratio1.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.23% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP27.52%
Div Incr Years0
Div Non Decr Years22
Ex-Date06-15 2026-06-15 (0.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.57 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.4 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-4.86
FCFYN/A
OCF(TTM)48.25
OCFY175.06%
SpS2855.14
BVpS913.07
TBVpS913.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 5.48% | ||
| ROCE | 0.54% | ||
| ROIC | 0.37% | ||
| ROICexc | 0.38% | ||
| ROICexgc | 0.38% | ||
| OM | 0.21% | ||
| PM (TTM) | 1.75% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score4
Asset Turnover1.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.32 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 96.64% | ||
| Cap/Sales | 1.86% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.1% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.11 |
F-Score4
WACC5.55%
ROIC/WACC0.07
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.74%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-4.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.46%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-102.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-82.15%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 8 PERP / CHSCP Fundamental Analysis FAQ
What is the fundamental rating for CHSCP stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.
What is the valuation status of CHS INC - CHSINC 8 PERP (CHSCP) stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.
What is the profitability of CHSCP stock?
CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 4 / 10.
How financially healthy is CHS INC - CHSINC 8 PERP?
The financial health rating of CHS INC - CHSINC 8 PERP (CHSCP) is 3 / 10.
Can you provide the dividend sustainability for CHSCP stock?
The dividend rating of CHS INC - CHSINC 8 PERP (CHSCP) is 8 / 10 and the dividend payout ratio is 27.52%.